Stay updated on Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab with or without radiation in recurrent or metastatic adenoid cystic carcinoma is displayed, including study design, participant criteria, and outcome measures. It also provides supporting study documents, publications, and record history.
    Difference
    54%
    Check dated 2026-11-07T10:54:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T09:37:41.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide notice announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T10:16:45.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:13:01.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer shows an updated site revision number, while the study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T12:39:03.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with the site's header and footer, indicating the study record is currently inaccessible due to an access issue.
    Difference
    19%
    Check dated 2026-09-19T18:43:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page.